FTH
Price
$28.25
Change
-$0.02 (-0.07%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
717.59M
39 days until earnings call
Intraday BUY SELL Signals
LIMN
Price
$3.93
Change
+$0.14 (+3.69%)
Updated
Oct 2, 04:51 PM (EDT)
Capitalization
5.74M
Intraday BUY SELL Signals
Interact to see
Advertisement

FTH vs LIMN

FTH vs LIMN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FTH vs. LIMN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTH is a Hold and LIMN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
FTHLIMN
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
24%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
42%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
45%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 11 days ago
56%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
20%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (FTH: $28.27 vs. LIMN: $3.79)
Brand notoriety: FTH and LIMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTH: 57% vs. LIMN: 10%
Market capitalization -- FTH: $717.59M vs. LIMN: $5.74M
FTH [@Biotechnology] is valued at $717.59M. LIMN’s [@Biotechnology] market capitalization is $5.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTH’s FA Score shows that 0 FA rating(s) are green while LIMN’s FA Score has 0 green FA rating(s).

  • FTH’s FA Score: 0 green, 5 red.
  • LIMN’s FA Score: 0 green, 5 red.
According to our system of comparison, FTH is a better buy in the long-term than LIMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTH’s TA Score shows that 5 TA indicator(s) are bullish while LIMN’s TA Score has 3 bullish TA indicator(s).

  • FTH’s TA Score: 5 bullish, 5 bearish.
  • LIMN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FTH is a better buy in the short-term than LIMN.

Price Growth

FTH (@Biotechnology) experienced а -2.69% price change this week, while LIMN (@Biotechnology) price change was -9.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

FTH is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
FTH
Daily Signal:
Gain/Loss:
LIMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXE85.961.87
+2.22%
Expand Energy Corporation
SHEN11.15-0.07
-0.62%
Shenandoah Telecommunications Co
WRBY27.49-0.29
-1.04%
Warby Parker
IMDX3.47-0.12
-3.34%
Insight Molecular Diagnostics Inc
MRM0.62-0.03
-5.18%
MEDIROM Healthcare Technologies

FTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTH has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FTH jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTH
1D Price
Change %
FTH100%
-4.94%
VSTM - FTH
47%
Loosely correlated
-1.86%
ALZN - FTH
40%
Loosely correlated
-23.12%
MOLN - FTH
39%
Loosely correlated
+5.22%
INAB - FTH
37%
Loosely correlated
+5.26%
GRI - FTH
37%
Loosely correlated
+1.55%
More

LIMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIMN has been loosely correlated with FTH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LIMN jumps, then FTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
+1.61%
FTH - LIMN
35%
Loosely correlated
-4.94%
UPB - LIMN
35%
Loosely correlated
-4.36%
IMMP - LIMN
34%
Loosely correlated
-2.37%
RNA - LIMN
32%
Poorly correlated
-1.69%
ALDX - LIMN
31%
Poorly correlated
+4.88%
More